InsidersTradesSigma
Vitrolife AB Stock: price and directors' dealings · Finland · FIN-FSA
Follow the Vitrolife AB stock price and the full insider trade history of the company, a listed equity based in Finland. Shares trade on FI FI, under the oversight of FIN-FSA. Operating in the Health Care sector, Vitrolife AB has recorded 3 public disclosures. Market capitalisation: €13.1bn. The latest transaction was reported on 6 February 2026 (Purchase). Among the most active insiders: Bronwyn Brophy O'Connor. The full history is openly available.
3
Insider Decl.
0
Thresholds
€98,038
3 ops.
Buy Volume
·
0 ops.
Sell Volume
36Σ signal
Fundamental score
Ranked 18,865 of 25,973 companies
36.5
score / 100
Value31
Quality42
FCF yld3.0%
Earn yld-38%
EV/EBITDA·
ROE-47%
Gross mgn58%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 6 February 2026
Declarations3 total
3,013 shares@ €8.38450.0002% mcap100.0% of flowAktieFI:A003V712-1
Ideal exit: 3 Nov 2026 (T+270)
6,470 shares@ €8.35920.0004% mcap100.0% of flowAktieFI:A003V709-1
Ideal exit: 3 Nov 2026 (T+270)
2,200 shares@ €8.49610.0001% mcap100.0% of flowAktieFI:A003V642-1
Ideal exit: 1 Nov 2026 (T+270)
3 of 3 declarations